What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to publicly announce and provide investors with Pfizer Inc.'s financial results for the fourth quarter and the full year of 2002.

Where can I find the detailed financial results for Q4 and FY 2002?

The detailed financial results are not presented directly in the 8-K filing itself. Instead, they are provided in a press release dated January 22, 2003, which is attached as Exhibit 99 and incorporated by reference into this report.

What does 'Regulation FD Disclosure' mean in this context?

Regulation FD (Fair Disclosure) ensures that all investors receive material information at the same time. By filing this 8-K with the press release, Pfizer is making its financial results available to the public broadly and simultaneously, preventing selective disclosure to certain investors.

Are there any significant business events or transactions reported in this 8-K?

This specific 8-K filing on January 22, 2003, is primarily focused on the disclosure of financial results for the fourth quarter and full year 2002. It does not appear to report other significant business events or transactions based on the provided text.

PFE 8-K SEC Disclosure — Jan 22, 2003

Summary

Pfizer Inc. filed this Form 8-K on January 22, 2003, primarily to report its financial results for the fourth quarter and the full year of 2002. This filing serves as a key disclosure mechanism, providing investors with timely updates on the company's performance. While the 8-K itself does not contain the detailed financial statements, it explicitly incorporates by reference a press release dated January 22, 2003, which would contain the comprehensive financial data and management commentary for the periods ended December 31, 2002.

Key Highlights

1Pfizer Inc. announced its financial results for the fourth quarter and full year 2002.
2The information was disclosed via a press release dated January 22, 2003.
3This filing is made under Regulation FD, ensuring broad public dissemination of material information.
4The 8-K report itself is brief, with the detailed financial data presented in the incorporated press release (Exhibit 99).
5The report confirms the company's incorporation in Delaware and its principal executive offices in New York.
6The filing date and earliest event date are both January 22, 2003.

PFIZER INC 8-K Report (Jan 22, 2003)

Summary

Key Highlights

Frequently Asked Questions